Vimarsana
Biggest News Aggregation in the World

Marla Dubinsky News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Marla Dubinsky. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Marla Dubinsky Today - Breaking & Trending Today

Redefining IBD Care: Intestinal Ultrasound's Emerging Role in Treat-to-Target Strategies - Vimarsana News

Redefining IBD Care: Intestinal Ultrasound's Emerging Role in Treat-to-Target Strategies

In honor of World Digestive Health Day, this feature examines the growth of intestinal ultrasound in IBD care in the US and how it aligns with STRIDE-II guidance.

Posting of Annual Report & Accounts & AGM Notice | Company Announcement - Vimarsana News

Posting of Annual Report & Accounts & AGM Notice | Company Announcement

Investegate announcements from Posting of Annual Report & Accounts & AGM Notice

EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat - Vimarsana News

EARNINGS: Videndum warns on recovery; AB Dynamics expects profit beat

The following is a round-up of earnings for London-listed companies, issued on Tuesday and not separately reported by Alliance News: ---------- AB Dynamics PLC - Wiltshire-based designer, manufacturer...

Marla Dubinsky, MD: The Importance of Head-to-Head Trials in IBD - Vimarsana News

Marla Dubinsky, MD: The Importance of Head-to-Head Trials in IBD

Dubinsky discusses the importance of head-to-head trials in IBD and looks ahead to the use of combination therapy to achieve desired treatment outcomes.

Marla Dubinsky, MD: Clinical Outcomes with Risankizumab Versus Ustekinumab in SEQUENCE - Vimarsana News

Marla Dubinsky, MD: Clinical Outcomes with Risankizumab Versus Ustekinumab in SEQUENCE

Dubinsky discusses findings from a post-hoc analysis of the head-to-head SEQUENCE trial of risankizumab versus ustekinumab in patients with Crohn disease refractory to anti-TNF therapy.